Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$447M |
| 2 |
STJ
St Jude Medical
STJ
|
+$321M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$281M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$276M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$556M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$411M |
| 3 |
ARG
Airgas Inc
ARG
|
+$314M |
| 4 |
US Bancorp
USB
|
+$187M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 3.42% |
| 2 | Energy | 2.84% |
| 3 | Technology | 2.82% |
| 4 | Healthcare | 2.45% |
| 5 | Consumer Discretionary | 2.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.75B
| $281K | ﹤0.01% |
3,145
-3,825
| -55% | -$351K |
|
4102
Innoviva
INVA
$1.51B
| $281K | ﹤0.01% |
26,716
-60,251
| -69% | -$713K |
|
4103
SBA Communications
SBAC
$18.9B
| $281K | ﹤0.01% |
2,601
-8,741
| -77% | -$887K |
|
4104
Bruker
BRKR
$7.99B
| $279K | ﹤0.01% |
12,250
+8,473
| +224% | +$226K |
|
4105
CALL
Cal-Maine
CALM
$4.02B
| $279K | ﹤0.01% |
6,300
+3,000
| +91% | +$141K |
|
4106
Donaldson
DCI
$11.3B
| $279K | ﹤0.01% |
8,125
-3,017
| -27% | -$101K |
|
4107
IMAX
IMAX
$2.78B
| $279K | ﹤0.01% |
9,479
-38,424
| -80% | -$1.21M |
|
4108
Koppers
KOP
$981M
| $279K | ﹤0.01% |
9,096
-10,143
| -53% | -$263K |
|
|
ADXS
4109
PUT
DELISTED
Advaxis Inc
ADXS
| $278K | ﹤0.01% |
2,293
+1,086
| +90% | +$139K |
|
4110
PetMed Express
PETS
$42.1M
| $277K | ﹤0.01% |
14,756
-1,484
| -9% | -$27.3K |
|
|
ERF
4111
DELISTED
Enerplus Corporation
ERF
| $277K | ﹤0.01% |
42,166
+27,821
| +194% | +$150K |
|
|
EXD
4112
DELISTED
Eaton Vance TaxManaged Buy-Write Strategy Fund
EXD
| $277K | ﹤0.01% |
22,688
-2,707
| -11% | -$32.9K |
|
4113
M/I Homes
MHO
$3.81B
| $276K | ﹤0.01% |
14,647
-15,762
| -52% | -$297K |
|
|
ATHN
4114
PUT
DELISTED
Athenahealth, Inc.
ATHN
| $276K | ﹤0.01% |
2,000
+300
| +18% | +$39.7K |
|
|
APB
4115
DELISTED
Asia Pacific Fund
APB
| $276K | ﹤0.01% |
28,259
+11,996
| +74% | +$114K |
|
|
AGD
4116
abrdn Global Dynamic Dividend Fund
AGD
$317M
| $275K | ﹤0.01% |
32,529
+8,110
| +33% | +$69.1K |
|
4117
Harmony Gold Mining
HMY
$11.3B
| $275K | ﹤0.01% |
76,419
+19,704
| +35% | +$68.2K |
|
|
NPKI
4118
NPK International
NPKI
$1.15B
| $275K | ﹤0.01% |
47,452
-40,009
| -46% | -$196K |
|
|
BRS
4119
DELISTED
Bristow Group, Inc.
BRS
| $275K | ﹤0.01% |
24,141
-12,216
| -34% | -$206K |
|
|
EGL
4120
DELISTED
Engility Holdings, Inc.
EGL
| $275K | ﹤0.01% |
13,036
-8,655
| -40% | -$183K |
|
4121
Weis Markets
WMK
$1.85B
| $274K | ﹤0.01% |
5,428
-12,954
| -70% | -$619K |
|
|
AMSG
4122
DELISTED
Amsurg Corp
AMSG
| $274K | ﹤0.01% |
3,539
-37,884
| -91% | -$2.93M |
|
4123
PUT
Arbutus Biopharma
ABUS
$913M
| $273K | ﹤0.01% |
78,500
+23,900
| +44% | +$101K |
|
4124
ArcBest
ARCB
$3.17B
| $273K | ﹤0.01% |
16,784
-10,142
| -38% | -$184K |
|
4125
CBIZ
CBZ
$2.97B
| $273K | ﹤0.01% |
26,239
-17,905
| -41% | -$184K |
|
Similar funds
Citigroup's Q2 2016 Portfolio in Review
As of Q2 2016, Citigroup held 8,012 positions worth $98B, up 10% from $89B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup deployed $6.55B of net new capital in Q2 2016, opening 331 new positions and adding to 2,391 existing holdings. Its largest new stake was US Foods: 1,274,383 shares worth $30.9M.
By sector, the portfolio is most concentrated in Financials at 3.4% of assets, down from 4.2% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $556M trimmed.
- Citigroup's largest Q2 2016 buy was US Foods: 1,274,383 shares worth $30.9M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $447M increase.
- Citigroup's biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $556M.
- Citigroup fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $411M.
- Citigroup's ten largest holdings make up 30% of its $98B portfolio in Q2 2016.
- Citigroup opened 331 new positions and closed 861 in Q2 2016.
- Citigroup's portfolio value rose 10% quarter-over-quarter to $98B.
Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.